| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 25 |
| 1 | OCTREOTIDE ACETATE | 25 |
| 2 | PACLITAXEL | 20 |
| 3 | EVEROLIMUS | 17 |
| 4 | CARBOPLATIN | 16 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 14 |
| 6 | GEMCITABINE HYDROCHLORIDE | 12 |
| 7 | CAPECITABINE | 9 |
| 8 | DENOSUMAB | 9 |
| 9 | DOCETAXEL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYRAPONE | 1 | 0.0010 |
| 1 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 2 | NERATINIB | 2 | 0.0009 |
| 3 | SACITUZUMAB GOVITECAN | 4 | 0.0008 |
| 4 | OCTREOTIDE ACETATE | 25 | 0.0008 |
| 5 | ALDESLEUKIN | 1 | 0.0008 |
| 6 | RADIUM RA 223 DICHLORIDE | 4 | 0.0008 |
| 7 | PSYLLIUM HUSK | 1 | 0.0007 |
| 8 | SARGRAMOSTIM | 1 | 0.0006 |
| 9 | VANDETANIB | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 38 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 27 |
| 2 | Microtubule Inhibitor [EPC] | 26 |
| 3 | Platinum-based Drug [EPC] | 24 |
| 4 | mTOR Inhibitor Immunosuppressant [EPC] | 17 |
| 5 | Corticosteroid [EPC] | 15 |
| 6 | Benzodiazepine [EPC] | 13 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 8 | Aromatase Inhibitor [EPC] | 10 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 3 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Estrogen Receptor Antagonist [EPC] | 8 | 0.0002 |
| 6 | Microtubule Inhibitor [EPC] | 26 | 0.0002 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 27 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Sulfone [EPC] | 1 | 0.0001 |